Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Aug 2: Taiho Oncology picked up a label expansion for its cancer drug Lonsurf (tipiracil), alone or as part of a combination regimen with Roches Avastin (bevacizumab) in metastatic colorectal cancer (mCRC)
Their decline is associated with the aging process by potentially increasing the production of telomerase
This accelerated healing timeline translates to reduced recovery periods and faster return to functional capacity
All content is peer-reviewed and regularly updated to ensure compliance with our editorial standards
US$ 20.62
US$ 22.51
US$ 26.11
US$ 29.55
US$ 28.90
US$ 24.38
